Meetings & Deadlines
2024 Calendar and Submission Deadlines Heading link
| Month | Deadline to Submit HGT Protocol* | Deadline to Submit Non- HGT Protocol | Meeting Date | Notify PI By |
|---|---|---|---|---|
| January 2024 | December 14, 2023 | December 14, 2023** | January 11, 2024 | January 16, 2024 |
| February 2024 | January 11, 2024 | January 24, 2024 | February 8, 2024 | February 12, 2024 |
| March 2024 | February 8, 2024 | February 28, 2024 | March 14, 2024 | March 18, 2024 |
| April 2024 | March 14, 2024 | March 27, 2024 | April 11, 2024 | April 15, 2024 |
| May 2024 | April 11, 2024 | April 24, 2024 | May 09, 2024 | May 13, 2024 |
| June 2024 | May 13, 2024 | May 29, 2024 | June 13, 2024 | June 16, 2024 |
| July 2024 | June 13, 2024 | June 26, 2024 | July 11, 2024 | July 15, 2024 |
| August 2024 | July 11, 2024 | July 24, 2024 | August 08, 2024 | August 12, 2024 |
| September 2024 | August 08, 2024 | August 28, 2024 | September 12, 2024 | September 16, 2024 |
| October 2024 | September 12, 2024 | September 25, 2024 | October 10, 2024 | October 15, 2024 |
| November 2024 | October 10, 2024 | October 30, 2024 | November 14, 2024 | November 12, 2024 |
| December 2024 | November 14, 2024 | November 27, 2024 | December 12, 2024 | December 16, 2024 |
deadline Heading link
* Any investigator planning to submit a study involving Human Gene Transfer (HGT) or Infectious Agents must contact IBC office prior to submission of the study to discuss study scope and required documentation. HGT and Infectious Agents used in humans are defined as follows:
1) deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into one or more human subjects (in vivo transfer);
2) deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into cells that will be transferred into one or more human subjects (ex vivo transfer);
3) deliberate transfer of synthetic nucleic acid molecules, or DNA or RNA derived from synthetic nucleic acid molecules, that meet any one of the following criteria:
a) Contain more than 100 nucleotides; or
b) Possess biological properties that enable integration into the genome (e.g., cis elements involved in integration); or
c) Have the potential to replicate in a cell; or
d) Can be translated or transcribed
4) infectious agents- any agent that is nonrecombinant in nature that is BSL 2 such as some vaccines or toxins.
** Please note that this deadline is earlier than other months due to holiday schedule.
Should you have any questions, please contact the IBC office at oacib@uic.edu